Ana Pedrero Gil: Navigating Anemia Management in Patients With Stroke or Malignancy History
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn, about a recent article by Rammdeep Saini, published in Canadian Journal of Kidney Health and Disease, adding:
“Erythropoiesis-stimulating agents (ESAs) are commonly used to manage chronic kidney disease (CKD) associated anemia.
There is a paucity of clear guidelines on their use in patients with CKD and with history of stroke or malignancy.”
Title: A Canadian Survey of Prescribing Practices of Erythropoiesis-Stimulating Agents in Dialysis-Dependent and Non-Dialysis-Dependent Chronic Kidney Disease
Authors: Rammdeep Saini, Keigan More, Jo-Anne S. Wilson, David A. Clark, Amanda J. Vinson, David Collister, Mark Canney, and Karthik K. Tennankore
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 26, 2026, 09:49Manuel Monreal: Acute VTE in Patients With Severe Renal Insufficiency
-
Sep 26, 2026, 09:38New TIF Guidelines for Emergency Care in Thalassaemia and SCD
-
Sep 26, 2026, 09:28Annette Bowyer: Rethinking Product Specific Calibrators in Haemophilia
-
Sep 26, 2026, 09:21Nisanth Menon: When Emergency Medicine Meets Transfusion Medicine
-
Sep 26, 2026, 07:50Giuseppe Andò: P2Y12 Inhibition in Diabetes – A Personalized Approach
-
Sep 26, 2026, 07:36Tiffany Hall: Honored to Be Recognized for Advancing Blood Health
-
Sep 26, 2026, 07:23Jignesh Patel: Call for Papers on Safer IV Unfractionated Heparin Use
-
Sep 26, 2026, 07:13Denise Braendgaard: OneSCD Brings Sickle Cell Disease to the Global Stage
-
Sep 26, 2026, 07:03Robert Tadevosyan: From Scientific Day to the Stago Factory